Ultramicrosize Griseofulvin
NDC 62135-495, Griseofulvin, tablet, from Chartwell RX, LLC..
- Product NDC
- 62135-495
- Status
- Listed
- Labeler
- Chartwell RX, LLC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA061996
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-495 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GRISEOFULVIN250 mg/1
Pharmacologic classes
Decreased Mitosis [PE]; Microtubule Inhibition [PE]; Tubulin Inhibiting Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-495-01 | 62135049501 | 100 TABLET in 1 BOTTLE, PLASTIC (62135-495-01) |
| 62135-495-30 | 62135049530 | 30 TABLET in 1 BOTTLE, PLASTIC (62135-495-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/efb8a660-802c-4ca6-bbff-ad7b48b91aefNADAC price for package 62135049501
GET /v1/drugs/nadac/62135049501NADAC price for package 62135049530
GET /v1/drugs/nadac/62135049530
Use it
Look up 62135-495 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-495 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-495. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.